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Abstract
Attention deficit/hyperactivity disorder (ADHD) is the most prevalent childhood psychiatric condition. It frequently persists
into adulthood and can have serious health and other adverse consequences. The majority of previous adult ADHD studies
have focused on young adults so that relatively little is known about ADHD symptoms and their effects in mid and late life.
In addition, effects of subclinical levels of attention deficit and hyperactivity have not been studied in detail. In this study we
investigated ADHD symptoms and related impairment in a large population-based sample of middle-aged Australian adults
(n=2091; 47% male). Applying the WHO adult ADHD Self Report Screener (ASRS) we observed that 6.2% of participants had
scores that were previously associated with ADHD diagnosis. No significant gender difference in the distribution of ASRS
scores was observed. Multiple regression analyses indicated strong positive correlations between symptoms of ADHD and
depression/anxiety and significant negative associations (p,0.01) with employment, financial stress, relationship quality,
health and well-being measures in this age group. Importantly, associations were highly significant even when few ADHD
symptoms were reported. Compared to the hyperactivity component, the inattention trait was particularly strongly
associated and remained significant after controlling for depression/anxiety symptoms. Our study confirms previous
findings and significantly adds to existing literature especially for an age-group that has not been well-studied. Our results
suggest that ADHD symptoms continue to be associated with ill-health and functional impairment in mid-life and are,
therefore, likely to be a major, previously unrecognized source of late-life morbidity with associated social and economic
costs. Thus, there is a compelling need for better understanding and development of age-appropriate approaches to the
diagnosis and treatment of ADHD in mid- to late-life.
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Introduction
Attention Deficit/Hyperactivity Disorder (ADHD) is a treatable
neuropsychiatric disorder characterized by inattention, excessive
motor activity and impulsivity [1], which begins in childhood and
can persist across the lifespan. However, symptom patterns change
with age and become less obvious and specific in adults [2]. Most
adults predominantly exhibit problems with inattention, which
manifest as disorganization, forgetfulness, unreliability, and
difficulty in planning, task completion, task shifting and time
management [2,3]. These symptoms adversely affect multiple life
domains with serious negative impact on functioning in day-to-day
life. Adult ADHD is also associated with a wide range of other
disorders, such as mood and substance use disorders [2,4] and its
detrimental effect result in substantial public health and other costs
[5–9]. A recent meta-analysis study reported that the prevalence
estimate of adult ADHD is 2.5% with a significant interaction
effect of age and gender on the estimate [10]. Earlier studies had
reported estimates between 1.0 and 7.3% [11–22]. Although the
prevalence of ADHD is thought to decrease with age; these
estimates suggest that ADHD is one of the most common adult
psychiatric disorders. Moreover, the true population prevalence of
the disorder is likely to be higher since under-reporting of
symptom severity is common and because of problems with
current diagnostic methods applied to adults [2,23,24].
Clinical diagnosis of ADHD typically follows categorical
definitions codified in The Diagnostic and Statistical Manual of
Mental Disorders, 4
th edition, Text Revision (DSM-IV-TR) [25].
However, accumulating evidence strongly supports ADHD
symptoms as being dimensional rather than categorical with the
disorder existing at the extremes of symptom distributions [26]. It
has been suggested that the dimensional approach is likely to
capture clinical and research data far more effectively than the
categorical approaches currently used [27]. ADHD symptoms are
also quite common; Arcos-Burgos et al. (2007) [28] reported that
nearly 60% of the general population displays some symptoms of
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ADHD symptoms who never meet the DSM threshold for
diagnosis are also significantly impaired and have a milder form
of the disorder [29,30]. However, effects of few and/or mild
symptoms have not been studied in detail.
While awareness of adult ADHD has increased over the last
decade, we know relatively little about the disorder in older adults.
Few studies [10,21,22,31] have included individuals over the age
of 45 years when estimating prevalence rate in adult populations.
Guldberg-Kjar and Johansson (2009) [32] studied self-rated
ADHD symptoms in 65–80 year old Swedish adults and reported
a prevalence rate of 3.3%, which is comparable to that in the
younger age-groups. It has also been suggested that older adults
with ADHD suffer from cumulative consequence of the disorder
over the lifespan, which affects quality of life at late-age [33].
Thus, persistence of ADHD and its adverse consequences into late
life has important public health implications. Since ADHD is a
treatable condition, greater emphasis on its diagnosis and
treatment in older people might result in sizeable reductions in
late-age morbidity.
There has been increasing recognition that midlife represents a
critical period where interventions could lead to healthier and
more productive ageing. However, this age-group has been largely
neglected with respect to mental health research as much of the
focus is on the young or the elderly. In this study we investigated
the impact of self-reported ADHD symptoms on a range of
measures of health, work, social life, relationship, well-being and
anxiety/depression symptoms in a large population-based sample
of middle-aged adults. We used the World Health Organization’s
adult ADHD Self Report Screener (ASRS) [34] questionnaire
(widely used in epidemiological setting) and followed methods
reported by Kessler et al. (2005; 2007) [34,35] to score individuals,
which allowed us to identify individuals with few and/or mild
symptoms. Furthermore, we investigated the relative impact of the
symptom dimensions of inattention and hyperactivity on func-
tional impairment. These methods allowed us to provide a
comprehensive view of the functional impairments experienced by
middle-aged adults with inattention and hyperactivity symptoms
that were not accounted for by co-occurring depression/anxiety
symptoms.
Methods
Ethics statement
All participants gave written informed consent to be included in
the Personality and Total health (PATH) project. The study was
approved by the Human Research Ethics Committee of The
Australian National University.
Participants
The study sample was drawn from the middle-aged cohort of
the PATH Through Life Project, which is a longitudinal study of
mental health and ageing [36]. Participants were residents of the
city of Canberra and the adjacent town of Queanbeyan in south-
eastern Australia and were recruited randomly from the electoral
roll (which provides a good representative population sample
because enrolment to vote is a legal requirement for all adult
Australian citizens). Further information on this cohort can be
found in the report by Anstey et al. (2011) [36]. Respondents are
interviewed every four years, with three waves of data collection
completed to date. Participants were surveyed for potential risk
factors and moderators of mental health.
The present study used data from the third wave of assessment
(the ASRS scale was introduced in this wave), which included 2179
individuals aged 47–54 years (mean age 50.761.5 years). Twenty-
five participants (1.2%) failed to complete the ASRS question-
naire. These non-responders did not significantly (p.0.05) differ
from the responders with respect to any of the sociodemographic
variables. A further 63 participants who reported having epilepsy,
brain tumor/infection or severe head injury were excluded,
leaving a sample of n=2092 (47% male) available for this
investigation. One participant reported being prescribed Dexam-
phetamine, which is used for treating ADHD. Inclusion or
exclusion of this participant did not affect the result of our analyses
(only results with this participant excluded are reported).
Measures
All self-report measures used in this study were obtained using
validated instruments. The ASRS was developed by the World
Health Organization and the short form of the screener consists of
a checklist of six questions regarding symptoms of ADHD based
on the diagnostic criteria of DSM-IV-TR [34,35]. Each item
requires respondents to rate on a five-point response scale from
‘‘never’’ [0] to ‘‘very often’’ [4] how frequently a particular
symptom of ADHD occurred over the past six months. A
summary score with a theoretical range of 0–24 was obtained as
an equally weighted sum of response scores for all questions.
Higher scores indicate increased risk of ADHD. Based on the
classification methods recommended by Kessler et al (2005, 2007)
[34,35] participants were grouped into: (i) binary categories using
a cutoff score of 13 (scores 14–24 being indicative of possible
ADHD) or (ii) four strata with the following score ranges: 0–9
(stratum I), 10–13 (stratum II), 14–17 (stratum III) and 18–24
(stratum IV). To explore these dimensions separately we used an
equally weighted sum of response scores for the first four items of
the screener related to inattention as the Inattention Trait Score
(ITS) and of response scores for the last two items related to
hyperactivity as the Hyperactivity Trait Score (HTS).
Categorical measures related to employment status, financial
stress and married/cohabiting relationship were generated from
responses to questions such as ‘‘How would you describe your
current employment status?’’, ‘‘Have you or your family had to go
without things you really needed in the last year because you were
short of money?’’, ‘‘Are you currently in a relationship with
someone?’’ and ‘‘How many times have you been married or lived
in a de facto relationship?’’. The 7-item short form of Dyadic
Adjustment Scale (DAS-7) was used to measure adjustment in a
married or cohabiting relationship. An equally weighted sum of
the response scores for the seven items was used the DAS-7 total
score [37]. The Lubben social network scale (LSNS) has been used
extensively to assess social integration and to screen for social
isolation. We used the abbreviated version of the scale with six
items (LSNS-6; [38]), three of which relate to kinship ties and the
remaining three to non-kin ties. The total scale score was an
equally weighted sum of response scores for all the items (range 0–
30).
Health-related quality of life was measured using RAND-12,
which contains 12 items from the eight scales of the RAND-36
Health Status Inventory [39]. A set of six questions creates the
physical health composite while the remaining six creates the
mental health composite. Each scale is scored using a one
parameter Rasch model based on Item Response Theory [39].
Depression and anxiety symptoms were assessed using items from
the section covering mood and panic disorders in the Patient
Health Questionnaire (PHQ). This is a short version of the patient
questionnaire component of the Primary Care Evaluation of
Mental Disorders (PRIME-MD) instrument [40]. We generated
measures of depression/anxiety- related disorders from the nine
ADHD Symptoms in Middle-Aged Adults
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from ‘‘not at all’’ (1) to ‘‘nearly every day’’ (4)] and the seven items
related to anxiety symptoms [rated on a 3-point scale from ‘‘not at
all’’ (1) to ‘‘more than half the days’’ (3)] following the coding
algorithm provided in the PHQ instruction manual. Participants
also reported on the use of medication for anxiety and depression.
The three separate components of subjective well-being –
positive affect (reflecting enthusiastic, alert and active feelings),
negative affect (reflecting subjective distress and unpleasurable
engagement) and life satisfaction [41] were measured using two
scales - the Positive and Negative Affect Schedule (PANAS;) [42]
and the satisfaction with life scale (SWLS;) [43]. PANAS has 20
items, 10 for each affect type. Responses to each item were scored
on a 5-point scale from ‘‘very slightly’’ (1) to ‘‘extremely’’ (5). An
equally weighted sum of the response scores for items in each
subscale was used as the total scale score (range 10–50). The
SWLS has 5 items each scored on a 7-point scale ranging from
‘‘strongly agree’’ (1) to ‘‘strongly disagree’’ (7). The total scale score
was an equally weighted sum of the response scores for the five
items, with a range of 5–35.
Statistical analysis
All statistical analyses were conducted using SPSS 18 (Chicago:
SPSS Inc.). Means and standard deviations were computed for the
ASRS total score, ITS and HTS. Comparisons between males and
females were performed using Student’s t-tests and Pearson’s Chi-
square tests for the continuous and categorical ASRS measures
respectively. Associations between the symptoms of ADHD and
depression/anxiety symptoms, employment status, financial prob-
lems, RAND-12, PAS, NAS, SWLS, DAS-7 and LSNS-6 scores
were analyzed using linear or logistic regressions as appropriate.
Age, sex and total years of education were included as covariates
in all models. Depression and anxiety symptoms were included as
additional covariates in models as indicated. Regression models
were generated by entering the covariates first, followed by the
predictors. Change in R
2 value between each step and the p value
associated with the R
2 change were noted. For simplicity in
interpretation we report results that were significant at the
stringent a level of 0.01 instead of the more commonly used level
of a=0.05. However, the majority of results remained significant
after applying Bonferroni corrections at an a=0.05.
Results
ADHD symptoms at midlife
For each individual item on the ASRS questionnaire, the
frequency of participants responding to each point of the response
scale is shown in Table 1. The proportion of participants reporting
‘‘often’’ or ‘‘very often’’ varied for individual items, ranging from
6–17%. The ASRS total score followed an approximate normal
distribution in this sample (Figure 1A) with a mean score of 8.2
and a standard deviation of 3.4. To distinguish possible ADHD
cases from non-cases at the individual level we applied both the
dichotomous and the four-strata classification schemes as suggest-
ed by Kessler et al (2007) [35]. Using the dichotomous
classification scheme, 6.2% of participants had scores equal to or
above the cut-off score of 14, which has been previously associated
with ADHD diagnosis. When the four-strata classification scheme
was applied, 67.3%, 26.5%, 5.2% and 1% of participants were
present in strata I, II, III and IV, respectively. The four-strata
classification was reported to have strong concordance with
clinical diagnosis with stratum IV most likely and stratum I least
likely to contain ADHD cases. Strata II and III represents those
with few and/or mild ADHD symptoms and might represent
subthreshold cases. We also found no significant difference
between males and females in either the continuous or categorical
ASRS measures (Table 2).
To assess ADHD symptom dimensions of inattention and
hyperactivity, we calculated inattention and hyperactivity item
scores separately. These scores referred to as trait scores (ITS and
HTS) were normally distributed in our sample with means and
standard deviations of 5.362.7 and 2.861.7, respectively. There
was no significant difference between males and females for either
trait, although a non-significant trend towards higher ITS in males
was observed (Table 2). While ITS was significantly correlated to
HTS (Pearson’s r=0.199, p,0.001), we observed that even when
participants reported ‘‘often’’ or ‘‘very often’’ for all inattention
items (n=23) their HTS scores were distributed over the entire
range of the scale (Figure 1B). A similar distribution was observed
for hyperactivity items (n=103) and ITS scores (Figure 1C).
Hence, for all subsequent analyses we present results separately for
ITS and HTS as continuous measures of ADHD symptoms. We
also present results for the four ASRS strata as a categorical
classification of ADHD symptoms, as recommended by Kessler
et al (2007) [35], to enable our results to be compared with clinical
studies.
ADHD symptoms are highly correlated with symptoms of
depression and anxiety
We observed significant associations between ADHD symptoms
and both depression and anxiety symptoms (Table 3). Compared
to the stratum I of the ASRS, a significantly higher proportion of
participants in all the other strata report the presence of depression
or anxiety symptoms. Use of anxiety and depression medication
was also higher in strata II, III and IV compared to stratum I.
Further, after adjusting for age, sex and years of education, the
odds of reporting depression or anxiety symptoms increased
significantly with increase in either ITS and HTS (Table 4). The
odds are also significantly higher for the ASRS strata II, III and IV
compared to stratum I (Table 5). These results demonstrate that
there is substantial overlap between ADHD and depression/
anxiety symptoms in this age group. This is also true when few
and/or mild ADHD symptoms were reported. We did not find
any gender difference in the association between ADHD and
depression/anxiety symptoms.
ADHD symptoms correlate with employment status and
financial stress
In our sample 8.0% and 16.7% of participants reported being
currently unemployed and having financial problems respectively.
ITS and HTS do not significantly alter the odds of being currently
employed although there was a trend towards lower odds of being
employed for higher ITS (Table 4). In addition, individuals who
reported having financial problems had significantly higher scores
for both ITS and HTS (Table 4). Participants in strata II and III
had significantly higher odds of experiencing financial problems
while participants in ASRS stratum III also had lower odds of
being employed compared to stratum I (Table 5). A similar pattern
was detected for stratum IV, which did not reach significance,
possibly reflecting the relatively small number of participants in
this stratum.
Inattention symptoms significantly affect multiple life
domains in mid-life
In our sample 18.1% reported not having a partner and 40.0%
reported being separated or being divorced. Neither trait score was
significantly associated with having a partner or being separated/
ADHD Symptoms in Middle-Aged Adults
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more marriages/relationships had significantly higher HTS but
not ITS when compared to those reporting only one marriage/
relationship (p,0.01). No significant difference was observed when
‘‘never being married or in a relationship’’ was included in the
analysis. Significant associations are also observed between ITS
and measures of cohabiting/marital relationship adjustment
(DAS-7), health related quality of life (RAND-12), subjective
well-being (PANAS and SWLS), social interactions (LSNS-6) and
affect (PAS and NAS; Table 6). However, only the health and
affect measures are significantly associated with HTS. With the
exception of NAS, all the other variables are negatively associated
with ADHD symptoms. When ASRS strata was the predictor
variable, the results are very similar to those obtained for the ITS
(Tables 5 and 6). Interestingly, associations were highly significant
for both strata II and III. However, in some cases the difference
between strata I and IV did not reach statistical significance,
probably because there are very few individuals in stratum IV.
Depression and anxiety symptoms also affect functioning in the
domains we investigated and since in our sample ADHD and
depression/anxiety symptoms were highly correlated, we exam-
ined whether the significant associations reported above were
confounded by the presence of depression/anxiety symptoms. We
generated regression models controlling for depression and
anxiety measures in addition to age, sex and years of education
for all variables for which we had previously detected significant
associations with ADHD symptoms. Using ITS and HTS as
predictors we observed that after controlling for depression and
anxiety symptoms, all associations with ITS remain significant,
but only scores for positive and negative affect remain
significantly associated with HTS (Table 6). When the predictor
was ASRS strata, association with all but RAND-12 physical
health and PAS scores remain statistically significant (Table 6).
The differences were most significant for comparisons between
stratum I and stratum III (also stratum II for some variables) but
not stratum IV, probably because very few individuals were
Figure 1. Distribution of ASRS score, HTS and ITS. A) ASRS total score shown separately for males and females. B) HTS shown if responses to all
inatention-related ASRS items were ‘‘often’’ or ‘‘very often’’; C) ITS shown if responses to all hyperactivity-related ASRS items were ‘‘often’’ or ‘‘very
often’’.
doi:10.1371/journal.pone.0031500.g001
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ADHD symptoms affect health, subjective well-being, ability to
interact socially and maintain healthy relationships in middle-
aged individuals independent of their depression/anxiety symp-
toms. This is true even when few ADHD symptoms were
reported and impairments were primarily associated with
inattention symptoms.
Discussion
In this study we investigated self-reported inattention and
hyperactivity symptoms in a large community-based sample of
middle-aged adults. The narrow age range of our sample allowed
us to perform focused investigations in this age group without the
confounding effects of age. We evaluated multiple symptomatic
and functional domains, which allowed us to present a
comprehensive picture of impairments associated with ADHD
symptoms. We confirm earlier findings from samples of young
ADHD adults and additionally report that middle-age individuals
experiencing few symptoms are significantly impaired in several
domains including work and social life. Our study is thus a
significant addition to existing literature especially in an age group
that has not been well studied but which is critically important in
the context of promoting healthy ageing. While the clinical status
of participants could not be confirmed our results clearly
demonstrate the substantial burden associated with ADHD
symptoms in middle age. Inattention symptoms are associated
with significantly more functional impairment than hyperactivity
symptoms. While most of our results closely follow the observa-
tions made previously in clinical samples of younger age groups,
some differences are apparent. Several factors could have
contributed to these differences. An obvious factor is that our
sample represents an age group not extensively studied for ADHD
and associated impairment and hence, there is limited scope for
direct comparison with existing studies. In addition, our sample is
more representative of the general middle-aged population
compared to the referred or convenience samples that have been
more widely studied. It is important to note in this context that our
results refer specifically to inattention and hyperactivity symptoms
and not clinically diagnosed ADHD cases.
The present study did not include diagnostic assessment of
participants and was not designed to estimate prevalence rates of
ADHD in middle age. Nevertheless, following the dichotomous
classification of the ASRS scores 6.2% of our sample fell within the
score range that had previously been associated with the diagnosis
of ADHD. The ASRS score had high concordance with the
clinical status of subjects in validation studies [35]. Our estimate
thus provides an indication of the prevalence of ADHD in this
population. Furthermore, the proportion of possible ADHD cases
in our sample falls within the range of prevalence rates previously
reported in adult samples [11–22].
Gender differences
In our sample ADHD symptoms were not significantly different
between males and females. This result is contrary to some
previous reports, which found significantly higher prevalence of
ADHD in males [10], but is consistent with findings from another
recent study of a large representative population sample [31]. This
difference could be due to the fact that we report ADHD
symptoms and not clinically diagnosed cases. However, gender
difference in ADHD prevalence is known to be more extreme in
pediatric samples compared to adolescent and adult samples. It
has been reported that since childhood referrals are initiated by
parents and teachers, girls without the hyperactivity component of
ADHD are less likely to be clinically diagnosed [44]. In contrast,
women experience more internalizing problems than men, which
leads to higher rates of self-referrals in adulthood thereby
generating more balanced gender distributions in adult samples
[45].
Table 1. Frequency of responses to ASRS items.
ASRS items Never Rarely Sometimes Often Very often
Inattention
1. Trouble wrapping up project 333 (15.9%) 855 (40.9%) 701 (33.5%) 165 (7.9%) 37 (1.8%)
2. Difficulty getting things in order 390 (18.7%) 1039 (49.7%) 539 (25.8%) 98 (4.7%) 25 (1.2%)
3. Problems remembering appointments 420 (20.1%) 1075 (51.4%) 479 (22.9%) 95 (4.5%) 22 (1.1%)
4. Avoid or delay getting started 187 (8.9%) 778 (37.2%) 890 (42.6%) 186 (8.9%) 50 (2.4%)
Hyperactivity
5. Fidget or squirm hands or feet 369 (17.6%) 741 (35.4%) 629 (30.1%) 263 (12.6%) 89 (4.3%)
6. Overly active or compelled to do things 463 (22.1%) 802 (38.4%) 575 (27.5%) 181 (8.7%) 70 (3.3%)
ASRS: Adult ADHD Self Report Screener.
doi:10.1371/journal.pone.0031500.t001
Table 2. Gender differences in ASRS scores (Mean 6 s.d. for
continuous variables and frequency for categorical variables
shown).
Males Females t/x
2 df p
(n=993) (n=1098)
ASRS total score 8.363.5 8.063.3 1.568 2089 0.117
Inattention trait score 5.562.7 5.262.6 2.250 2089 0.025
Hyperactivity trait score 2.861.7 2.861.7 20.359 2089 0.719
ASRS strata 6.947 3 0.074
I (n=1408) 65.3% 69.1%
II (n=555) 28.1% 25.1%
III (n=109) 5.2% 5.2%
IV (n=20) 1.4% 0.5%
ASRS category 0.744 1 0.388
0–13 (n=1963) 93.4% 94.3%
14–24 (n=129) 6.6% 5.7%
ASRS: Adult ADHD Self Report Screener.
doi:10.1371/journal.pone.0031500.t002
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between ADHD symptoms and depression/anxiety scores or
measures of functional impairment. This result is consistent with
previous findings in clinically referred subjects [46] and suggests
that men and women experience ADHD in a similar way.
Depression and Anxiety
In our sample symptoms of ADHD very often co-occurred with
depression and anxiety symptoms. This has been observed in both
clinical and population samples of younger adults [20]. Even
among adults with few ADHD symptoms (Stratum II), and hence
unlikely to meet the threshold for a clinical diagnosis, the
associations with both depression and anxiety symptoms were
substantial. Also, both ITS and HTS were strongly associated with
depression and anxiety symptoms although the association with
inattention symptoms were much stronger. Because of the cross-
sectional nature of the study we could not ascertain whether
depression/anxiety symptoms were secondary to ADHD symp-
toms. The use of depression or anxiety medication is also
significantly higher among individuals with ADHD symptoms,
which is likely to contribute to higher medical costs and financial
stress.
General functioning
We observe trends suggesting that ADHD symptoms are
negatively associated with full-time employment and positively
associated with financial problems. In addition ADHD symptoms
are negatively associated with relationship quality, social life,
health and well-being. These findings are broadly consistent with
studies of adult ADHD patients or follow-up studies on children
with ADHD [21,47–49]. We also observe that these associations
remain significant even after removing the variance explained by
depression and anxiety symptoms. The effect is particularly strong
for inattention symptoms. Thus, in the general population,
individuals experiencing even few ADHD symptoms have
impaired functioning in personal and social domains, which
Table 3. Associations between ASRS strata and categorical classification of depression and anxiety symptoms.
ASRS strata x
2 df p
I II III IV
(n=1407) (n=551) (n=109) (n=20)
BPHQ depression categories 217.922 9 ,0.001
No depression (n=1800) 90.8% 82.2% 54.1% 55.0%
Subsyndromal (n=149) 5.8% 8.0% 18.3% 20.0%
Minor (n=71) 2.5% 5.1% 7.3% 0.0%
Major (n=66) 0.9% 4.7% 20.2% 25.0%
BPHQ anxiety symptoms 132.645 3 ,0.001
Absent (n=1995) 97.8% 93.9% 76.1% 75.0%
Present (n=96) 2.2% 6.1% 23.9% 25.0%
Anxiety/Depression medication use 70.725 3 ,0.001
No (n=1832) 91.8% 81.9% 73.4% 65.0%
Yes (n=251) 8.2% 18.1% 26.6% 35.0%
p,0.01 shown in bold.
BPHQ: Brief Patient Health Questionnaire.
doi:10.1371/journal.pone.0031500.t003
Table 4. Logistic regression model with ITS and HTS as predictors.
Inattention trait score Hyperactivity trait score
B p OR (95% CI) B p OR (95% CI) R
2
Depression
a 0.239 ,0.001 1.27 (1.21, 1.33) 0.117 0.003 1.12 (1.04, 1.21) 0.114
Anxiety
a 0.265 ,0.001 1.30 (1.21, 1.40) 0.203 0.001 1.23 (1.09, 1.38) 0.116
Employed
b 20.076 0.014 0.93 (0.87, 0.99) 20.049 0.316 0.95 (0.87, 1.05) 0.058
Financial stress
c 0.101 ,0.001 1.11 (1.06, 1.16) 0.098 0.005 1.10 (1.03, 1.18) 0.042
Partner present 20.038 0.086 0.96 (0.92, 1.10) 0.067 0.058 1.07 (1.00, 1.15) 0.016
Separated
d 0.029 0.099 1.03 (1.00, 1.07) 0.049 0.068 1.05 (1.00, 1.11) 0.010
Models adjusted for age, sex and total years of education.
p,0.01 shown in bold.
a‘‘symptoms absent’’ is the reference category.
b‘‘not currently employed’’ is the reference category.
c‘‘financial stress absent’’ is the reference category.
d‘‘never been separated or divorced’’ is the reference category.
OR: Odds Ratio; CI: Confidence Interval; R
2=Nagelkerke R
2.
doi:10.1371/journal.pone.0031500.t004
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impairments is likely to increase late-life morbidity, a significant
public health issue for countries with aging populations.
The main strength of this study was that it was conducted in a
large representative epidemiological sample, thereby avoiding the
potential biases associated with clinical samples and hence the
results are likely to be more generalisable to the middle-aged
population. Further, participants in our study represent an age
group that has not been well-studied for problems of attention
regulation (which have been more widely explored in children or
in older adults in relation to dementia). We included assessment of
multiple symptomatic and functional domains affected by ADHD
to provide a comprehensive description of functional impairment,
while earlier studies have largely focused on health status and
workplace impairment. We report extensive data on individuals
with fewer and/or milder ADHD symptoms (ASRS strata II and
III comprising of .30% of the participants), a group that has not
previously been studied in detail. Importantly, we report
significant impairment in health, personal and social domains in
this group, which often goes unnoticed. In addition, we report
results for continuous measures of ADHD symptoms, which allows
us to distinguish between inattention and hyperactivity related
impairment. Finally to better understand the co-occurrence
between ADHD and depression/anxiety symptoms we clearly
show how the regression results were affected by the inclusion or
exclusion of depression/anxiety symptoms in the model. This
comparison aids in gauging the unique contribution of ADHD
symptoms to impairment.
Table 5. Logistic regression models with ASRS strata as predictor.
ASRS strata
a
II III IV
B p OR (95% CI) B p OR (95% CI) B p OR (95% CI) R
2
Depression
b 0.814 ,0.001 2.26 (1.70, 3.00) 2.180 ,0.001 8.85 (5.80, 13.50) 2.280 ,0.001 9.78 (3.86, 24.81) 0.108
Anxiety
b 1.072 ,0.001 2.92 (1.76, 4.81) 2.645 ,0.001 14.08 (7.98, 24.84) 2.743 ,0.001 15.53 (5.24, 49.00) 0.128
Employed
c 0.045 0.824 1.05 (0.71, 1.55) 21.167 ,0.001 0.31 (0.18, 0.53) 21.354 0.024 0.26 (0.08, 0.84) 0.071
Financial stress
d 0.538 ,0.001
f 1.71 (1.32, 2.21) 0.974 ,0.001 2.65 (1.70, 4.12) 0.906 0.089 2.47 (0.87, 7.03) 0.038
Partner present 20.123 0.340 0.89 (0.69, 1.14) 20.069 0.790 0.93 (0.56, 1.55) 0.072 0.911 1.07 (0.31, 3.74) 0.012
Separated
e 0.129 0.210 1.14 (0.93, 1.39) 0.533 0.008 1.70 (1.15, 2.52) 1.048 0.029 2.84 (1.11, 7.32) 0.013
Models adjusted for age, sex and total years of education.
p,0.01 shown in bold.
aASRS strata I is the reference category.
b‘‘symptoms absent’’ is the reference category.
c‘‘not currently employed’’ is the reference category.
d‘‘financial stress absent’’ is the reference category.
e‘‘never been separated or divorced’’ is the reference category.
ftrend observed after adjusting for depression and anxiety symptoms.
OR: Odds Ratio; CI: Confidence Interval; R
2=Nagelkerke R
2.
doi:10.1371/journal.pone.0031500.t005
Table 6. Multiple regression models with inattention and hyperactivity trait scores or ASRS strata as predictors.
ADHD symptoms ASRS strata
a
ITS HTS II III IV
b p b p R
2 (change) b p b p b p R
2 (change)
DAS-7 20.208 ,0.001
c 0.003 0.910 0.045 (0.043)
b 20.112 ,0.001
d 20.172 ,0.001
c 20.016 0.510 0.039 (0.036)
b
LSNS-6 20.144 ,0.001
c 0.016 0.455 0.039 (0.020)
b 20.078 ,0.001 20.128 ,0.001
c 20.045 0.037 0.040 (0.021)
b
RAND-12 Physical 20.217 ,0.001
c 0.059 0.006 0.076 (0.055)
b 20.128 ,0.001 20.182 ,0.001
d 20.081 ,0.001 0.069 (0.047)
b
RAND-12 Mental 20.362 ,0.001
c 20.091 ,0.001 0.157 (0.150)
b 20.239 ,0.001
c 20.306 ,0.001
c 20.126 ,0.001 0.147 (0.140)
b
PAS 20.324 ,0.001
c 0.064 0.002
c 0.122 (0.099)
b 20.144 ,0.001 20.177 ,0.001 20.051 0.017 0.069 (0.046)
b
NAS 0.298 ,0.001
c 0.160 ,0.001
c 0.133 (0.132)
b 0.225 ,0.001
c 0.313 ,0.001
c 0.176 ,0.001
c 0.154 (0.152)
b
SWLS 20.299 ,0.001
c 20.005 0.821
d 0.095 (0.089)
b 20.160 ,0.001
c 20.207 ,0.001
c 20.097 ,0.001 0.072 (0.066)
b
Models adjusted for age, sex and total years of education.
p,0.01 shown in bold.
aASRS strata I is the reference category.
bsignificant R
2 change from previous model.
csignificant after adjusting for depression and anxiety symptoms.
dtrend observed after adjusting for depression and anxiety symptoms.
ITS: Inattention Trait Score; HTS: Hyperactivity Trait Score; DAS: Dyadic Adjustment Scale; LSNS: Lubben Social Network Scale; PAS: Positive Affect Schedule; NAS:
Negative Affect Schedule; SWLS: Satisfaction With Life Scale.
doi:10.1371/journal.pone.0031500.t006
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PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e31500This study has several limitations. First, information on ADHD
symptoms during childhood was unavailable and hence we could
not assess participants clinically using the current diagnostic
criteria. Similar limitations also apply to measures of depression
and anxiety symptoms, which were not diagnosed in clinical terms.
Nevertheless, the associations we observed between ADHD
symptoms and functional impairment was very similar to those
reported previously in both patient and population samples, albeit
in a younger age group. Second, all measures were based on self-
reports, which might not be completely accurate (e.g. social
desirability and current emotional state could introduce biases
[50,51]). However, the assessment instruments we used in this
study were reported to have good sensitivity and specificity, have
been validated in different cultural settings and have been used in
several reported studies [37–43].
In conclusion, we observed that a significant proportion of
middle-aged individuals in the general population report impair-
ment associated with ADHD symptoms – especially inattention
symptoms with both males and females being equally affected.
Irrespective of whether or not these individuals meet all the criteria
required for a clinical diagnosis of ADHD, the significant
functional impairment and depression/anxiety symptoms they
experience clearly demonstrates that the presence of these
symptoms constitutes a substantial burden for middle-aged adults.
For societies with a large aging population this burden, which is
currently unrecognized, is likely to result in significant costs for
individuals as well as the community. Impairment associated with
ADHD symptoms is responsive to interventions in children,
adolescents and young adults [52]. There is, therefore, a good
prospect that suitable intervention would reduce the substantial
negative impact of ADHD symptoms on health and quality of life
in older age groups that we have demonstrated here. Thus, there is
a compelling need to develop a greater understanding of the
presentation and impact of ADHD in later life and to develop age-
appropriate approaches to diagnosis and treatment.
Acknowledgments
The authors are grateful to Anthony Jorm, Bryan Rodgers, Helen
Christensen, Andrew Mackinnon, Chantal Reglade-Meslin, Patricia
Jacomb, Karen Maxwell and PATH interviewers.
Author Contributions
Conceived and designed the experiments: DD NC KA SE. Performed the
experiments: NC KA. Analyzed the data: DD NC PB. Contributed
reagents/materials/analysis tools: PB KA SE. Wrote the paper: DD.
References
1. Biederman J, Faraone SV (2005) Attention-deficit hyperactivity disorder. Lancet
366: 237–248.
2. Ro ¨sler M, Casas M, Konofal E, Buitelaar J (2010) Attention deficit hyperactivity
disorder in adults. World J Biol Psychiatry 11: 684–698.
3. Barkley R (2010) Attention Deficit Hyperactivity Disorder in Adults.
SudburyMassachusetts: Jones and Bartlett Publishers.
4. Karam RG, Bau CHD, Salgado CAI, Kalil KLS, Victor MM, et al. (2009) Late-
onset ADHD in adults: milder, but still dysfunctional. J Psychiatr Res 43:
697–701.
5. Bernfort L, Nordfeldt S, Persson J (2008) ADHD from a socio-economic
perspective. Acta Paediatr 97: 239–245.
6. Matza LS, Paramore C, Prasad M (2005) A review of the economic burden of
ADHD. Cost Eff Resour Alloc 3: 5.
7. Secnik K, Swensen A, Lage MJ (2005) Comorbidities and costs of adult patients
diagnosed with attention-deficit hyperactivity disorder. Pharmacoeconomics 23:
93–102.
8. Birnbaum HG, Kessler RC, Lowe SW, Secnik K, Greenberg PE, et al. (2005)
Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs
of persons with ADHD and their family members in 2000. Curr Med Res Opin
21: 195–206.
9. Swensen AR, Birnbaum HG, Secnik K, Marynchenko M, Greenberg P, et al.
(2003) Attention-deficit/hyperactivity disorder: increased costs for patients and
their families. J Am Acad Child Adolesc Psychiatry 42: 1415–1423.
10. Simon V, Czobor P, Ba ´lint S, Me ´sza ´ros A, Bitter I (2009) Prevalence and
correlates of adult attention-deficit hyperactivity disorder: meta-analysis.
Br J Psychiatry 194: 204–211.
11. Medina-Mora ME, Borges G, Lara C, Benjet C, Blanco J, et al. (2005)
Prevalence, service use, and demographic correlates of 12-month DSM-IV
psychiatric disorders in Mexico: results from the Mexican National Comorbidity
Survey. Psychol Med 35: 1773–1783.
12. Almeida Montes LG, Herna ´ndez Garcı ´a AO, Ricardo-Garcell J (2007) ADHD
prevalence in adult outpatients with nonpsychotic psychiatric illnesses. J Atten
Disord 11: 150–156.
13. Barbaresi W, Katusic S, Colligan R, Weaver A, Pankratz V, et al. (2004) How
common is attention-deficit/hyperactivity disorder? Towards resolution of the
controversy: results from a population-based study. Acta Paediatr Suppl 93:
55–59.
14. Bitter I, Simon V, Ba ´lint S, Me ´sza ´ros A, Czobor P (2010) How do different
diagnostic criteria, age and gender affect the prevalence of attention deficit
hyperactivity disorder in adults? An epidemiological study in a Hungarian
community sample. Eur Arch Psychiatry Clin Neurosci 260: 287–296.
15. DuPaul GJ, Schaughency EA, Weyandt LL, Tripp G, Kiesner J, et al. (2001)
Self-report of ADHD symptoms in university students: cross-gender and cross-
national prevalence. J Learn Disabil 34: 370–379.
16. Faraone SV, Biederman J (2005) What is the prevalence of adult ADHD?
Results of a population screen of 966 adults. J Atten Disord 9: 384–391.
17. Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, et al. (2007) Cross-
national prevalence and correlates of adult attention-deficit hyperactivity
disorder. Br J Psychiatry 190: 402–409.
18. Gadow KD, Sprafkin J, Schneider J, Nolan EE, Schwartz J, et al. (2007) ODD,
ADHD, versus ODD+ADHD in clinic and community adults. J Atten Disord
11: 374–383.
19. Heiligenstein E, Conyers LM, Berns AR, Miller MA, Smith MA (1998)
Preliminary normative data on DSM-IV attention deficit hyperactivity disorder
in college students. J Am Coll Health 46: 185–188.
20. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, et al. (2006) The
prevalence and correlates of adult ADHD in the United States: results from the
National Comorbidity Survey Replication. Am J Psychiatry 163: 716–723.
21. Kooij JJS, Buitelaar JK, Van Den Oord EJ, Furer JW, Rijnders CAT, et al.
(2005) Internal and external validity of attention-deficit hyperactivity disorder in
a population-based sample of adults. Psychol Med 35: 817–827.
22. Murphy K, Barkley RA (1996) Prevalence of DSM-IV symptoms of ADHD in
adult licensed drivers: Implications for clinical diagnosis. J Atten Disord 1:
147–161.
23. Manor I, Meidad S, Zalsman G, Zemishlany Z, Tyano S, et al. (2008) Objective
versus subjective assessment of methylphenidate response. Child Psychiatry
Hum Dev 39: 273–282.
24. Manor I, Rozen S, Zemishlani Z, Weizman A, Zalsman G (2011) When does it
end? Attention-deficit/hyperactivity disorder in the middle aged and older
populations. Clin Neuropharmacol 34: 148–154.
25. American Psychiatric Association (2000) Diagnostic and Statistical Manual of
Mental Disorders. ArlingtonVA: American Psychiatric Publishing Inc.
26. Barkley RA (2006) Attention-Deficit Hyperactivity Disorder: A Handbook for
Diagnosis. New York: The Gulliford Press.
27. Hyman SE (2010) The diagnosis of mental disorders: the problem of reification.
Annu Rev Clin Psychol 6: 155–179.
28. Arcos-Burgos M, Acosta MT (2007) Tuning major gene variants conditioning
humanbehavior:theanachronismofADHD.CurrOpinGenet Dev17:234–238.
29. Faraone SV, Biederman J, Doyle A, Murray K, Petty C, et al. (2006)
Neuropsychological studies of late onset and subthreshold diagnoses of adult
attention-deficit/hyperactivity disorder. Biol Psychiatry 60: 1081–1087.
30. Faraone SV, Biederman J, Spencer T, Mick E, Murray K, et al. (2006)
Diagnosing adult attention deficit hyperactivity disorder: are late onset and
subthreshold diagnoses valid? Am J Psychiatry 163: 1720–1729.
31. de Zwaan M, Gruß B, Mu ¨ller A, Graap H, Martin A, et al. (2011) The estimated
prevalence and correlates of adult ADHD in a German community sample. Eur
Arch Psychiatry Clin Neurosci.
32. Guldberg-Kjar T, Johansson B (2009) Old people reporting childhood AD/HD
symptoms: Retrospectively self-rated AD/HD symptoms in a population-based
Swedish sample aged 65–80. Nord J Psychiatry. pp 1–8.
33. Brod M, Schmitt E, Goodwin M, Hodgkins P, Niebler G (2011) ADHD burden
of illness in older adults: a life course perspective. Qual Life Res;DOI 10.1007/
s11136-11011-19981-11139.
34. Kessler RC, Adler L, Ames M, Demler O, Faraone S, et al. (2005) The World
Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening
scale for use in the general population. Psychol Med 35: 245–256.
35. Kessler RC, Adler LA, Gruber MJ, Sarawate CA, Spencer T, et al. (2007)
Validity of the World Health Organization Adult ADHD Self-Report Scale
ADHD Symptoms in Middle-Aged Adults
PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e31500(ASRS) Screener in a representative sample of health plan members.
Int J Methods Psychiatr Res 16: 52–65.
36. Anstey KJ, Christensen H, Butterworth P, Easteal S, Mackinnon A, et al. (2011)
Cohort Profile: The PATH through life project. Int J Epidemiol;DOI:10.1093/
ije/dyr1025.
37. Spanier GB (1976) Measuring dyadic adjustment: New scales for assessing the
quality of marriage and similar dyads. J Marr Fam 38: 15–28.
38. Lubben J, Blozik E, Gillmann G, Iliffe S, von Renteln Kruse W, et al. (2006)
Performance of an abbreviated version of the Lubben Social Network Scale
among three European community-dwelling older adult populations. Gerontol-
ogist 46: 503–513.
39. Maddigan SL, Feeny DH, Johnson JA, Investigators D (2004) Construct validity
of the RAND-12 and Health Utilities Index Mark 2 and 3 in type 2 diabetes.
Qual Life Res 13: 435–448.
40. Spitzer RL, Kroenke K, Williams JB (1999) Validation and utility of a self-report
version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation
of Mental Disorders. Patient Health Questionnaire. JAMA 282: 1737–1744.
41. Andrews FM, Withey SB (1976) Social indicators of well-being : Americans’
perceptions of life quality. New York: Plenum Press. pp 435–439.
42. Watson D, Clark LA, Tellegen A (1988) Development and validation of brief
measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol
54: 1063–1070.
43. Diener E, Emmons RA, Larsen RJ, Griffin S (1985) The Satisfaction With Life
Scale. J Pers Assess 49: 71–75.
44. Berry CA, Shaywitz SE, Shaywitz BA (1985) Girls with attention deficit disorder:
a silent minority? A report on behavioral and cognitive characteristics. Pediatrics
76: 801–809.
45. Gershon J (2002) A meta-analytic review of gender differences in ADHD. J Atten
Disord 5: 143–154.
46. Barkley RA, Brown TE (2008) Unrecognized attention-deficit/hyperactivity
disorder in adults presenting with other psychiatric disorders. CNS Spectr 13:
977–984.
47. Biederman J, Faraone SV (2006) The effects of attention-deficit/hyperactivity
disorder on employment and household income. MedGenMed 8: 12.
48. Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, et al. (1993)
Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in
adults with attention deficit hyperactivity disorder. Am J Psychiatry 150:
1792–1798.
49. Kessler RC, Adler L, Ames M, Barkley RA, Birnbaum H, et al. (2005) The
prevalence and effects of adult attention deficit/hyperactivity disorder on work
performance in a nationally representative sample of workers. J Occup Environ
Med 47: 565–572.
50. Neugebauer R, Ng S (1990) Differential recall as a source of bias in
epidemiologic research. J Clin Epidemiol 43: 1337–1341.
51. Brewin CR, Andrews B, Gotlib IH (1993) Psychopathology and early
experience: a reappraisal of retrospective reports. Psychol Bull 113: 82–98.
52. Antshel KM, Hargrave TM, Simonescu M, Kaul P, Hendricks K, et al. (2011)
Advances in understanding and treating ADHD. BMC Med 9: 72.
ADHD Symptoms in Middle-Aged Adults
PLoS ONE | www.plosone.org 9 February 2012 | Volume 7 | Issue 2 | e31500